LIVE

Serial Number

79352877

Owner

Genexine, Inc.

Attorney

LEIGH ANN LINDQUIST

Filing Date

Sep 1, 2022

Add to watchlist:

No watchlists yet

+ Create New Watchlist

View on USPTO

FIDVAXI Trademark

Serial Number: 79352877 • Registration: 7227043

FIDVAXI is a trademark filed by Genexine, Inc. on September 1, 2022. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Trademark Classes

Class 5 - Pharmaceuticals

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Owner Contact Info

Genexine, Inc. (16 trademarks)

(Magokdong, Bio Innovation Park) 172,

Entity Type: 98

Legal Representation

Attorney of Record

LEIGH ANN LINDQUIST

4,507 trademarks filed View all →

Correspondence Address

Leigh Ann Lindquist SUGHRUE MION, PLLC

2000 Pennsylvania Avenue NW, Suite 9000

Washington, DC 20006

UNITED STATES

Trademark Details

Filing Date

September 1, 2022

Registration Date

November 28, 2023

Published for Opposition

September 12, 2023

Goods & Services

Pharmaceutical products for the treatment of infectious diseases; Pharmaceutical preparations for the treatment of immune system related diseases and disorders, namely, immunomodulators; viral vaccines; pharmaceutical preparations for the treatment of viral diseases; vaccines; vaccine preparations; pharmaceutical preparations and substances for use in gynecology; pharmaceutical preparations and compositions for the treatment and prevention of cancer; pharmaceutical preparations and substances for the prevention of cancer; pharmaceutical products for the treatment of viral and infectious diseases of cancer patients; biopharmaceutical preparations for the treatment of cancer; biological preparations for the treatment of cancer; pharmaceutical preparations for the treatment of cancer; human vaccine preparations; pharmaceutical preparations for the treatment of tumors; pharmaceutical preparations for suppressing tumors

Filing History

NEW REPRESENTATIVE AT IB RECEIVED

Feb 7, 2025 NREP

FINAL DECISION TRANSACTION PROCESSED BY IB

Mar 26, 2024 FINO

FINAL DISPOSITION NOTICE SENT TO IB

Mar 4, 2024 FICS

FINAL DISPOSITION PROCESSED

Mar 4, 2024 FIMP

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

Feb 28, 2024 FICR

NOTICE OF REGISTRATION CONFIRMATION EMAILED

Nov 28, 2023 NRCC

REGISTERED-PRINCIPAL REGISTER

Nov 28, 2023 R.PR

NOTIFICATION PROCESSED BY IB

Sep 12, 2023 GPNX

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Sep 12, 2023 NPUB

PUBLISHED FOR OPPOSITION

Sep 12, 2023 PUBO

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

Aug 23, 2023 OPNS

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

Aug 23, 2023 OP2R

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Aug 23, 2023 NONP

APPROVED FOR PUB - PRINCIPAL REGISTER

Aug 4, 2023 CNSA

TEAS/EMAIL CORRESPONDENCE ENTERED

Jul 6, 2023 TEME

CORRESPONDENCE RECEIVED IN LAW OFFICE

Jul 6, 2023 CRFA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Jul 6, 2023 TROA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

Jun 13, 2023 TCCA

TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS

Jun 13, 2023 ECDR

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

Jun 13, 2023 ARAA

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

Jun 13, 2023 REAP

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

Jun 13, 2023 CHAN

TEAS CHANGE OF OWNER ADDRESS RECEIVED

Jun 13, 2023 COAR

REFUSAL PROCESSED BY IB

Feb 2, 2023 RFNT

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

Jan 12, 2023 RFCS

REFUSAL PROCESSED BY MPU

Jan 12, 2023 RFRR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

Nov 3, 2022 RFCR

NON-FINAL ACTION WRITTEN

Nov 2, 2022 CNRT

ASSIGNED TO EXAMINER

Nov 2, 2022 DOCK

APPLICATION FILING RECEIPT MAILED

Oct 25, 2022 MAFR

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Oct 21, 2022 NWOS

SN ASSIGNED FOR SECT 66A APPL FROM IB

Oct 20, 2022 REPR

Related Trademarks

More from this Owner

HYFC TECHNOLOGY

EFESA

More in Same Class